The Cigna Group with ticker code (CI) have now 21 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $400.00 and $287.00 and has a mean share price target at $368.52. (at the time of writing). Now with the previous closing price of $342.16 and the analysts are correct then there would likely be a percentage uptick in value of 7.7%. The 50 day MA is $311.50 and the 200 day MA is $288.87. The market capitalization for the company is 100.79B. The current share price for the company is: $344.59 USD
The potential market cap would be $108,559,114,247 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 19.45, revenue per share of $657.46 and a 3.77% return on assets.
The Cigna Group is a global health services company. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes a range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions, which are provided to health plans, employers, government organizations and health care providers. Cigna Healthcare includes the United States Commercial, United States Government, and International Health operating segments, which provide medical and coordinated solutions to clients and customers.
